The LDN 2016 Conference

We would like to thank all the speakers for taking part in the conference and for their amazing presentations.  

The LDN 2016 AIIC Conference was a major success and a milestone in LDN research and application of LDN as a treatment for multiple sclerosis, Crohn's disease, colitis, autism, cancer, IBS, lupus, fibromyalgia, rheumatoid arthritis, arthritis, chronic pain and other auto-immune diseases.  

Throughout the 3 day event, noted healthcare professionals presented the most recent LDN related data and treatments. They also offered compelling examples, experiences, and case studies from their experiences with patients who are using LDN as treatment for a range of immune-related diseases, and in many cases achieving positive, life-changing results.  

Attendance provided 12.5 CE credits from the Oregon Board of Naturopathic Medicine and 13.25 credits from The American Association of Naturopathic Practitioners

Crohn’s Disease - Paul Battle, PA-C

Low Dose Naltrexone in Pregnancy - Phil Boyle, MD

Mechanism of action of low dose naltrexone - Pradeep Chopra, MD

Chronic Pain, Opioids and LDN - Pradeep Chopra, MD

The Sinclair Method for Alcohol Addiction - Claudia Christian

LDN in Primary Care - Case Studies - Jill Cottel, MD

Clinical Hypnosis and Pain Control- Lachlan Cox

LDN Case Studies - Martin Dayton, DO

Pharmacokinetics, Pharmacodynamics, Interactions & Cautions in Common Practice - Stephen Dickson, BSC (hons), MRPharmS

Treatment of Psychiatric Disorders - Galyn Forster, MS, LPC

CFS/ME and Fibromyalgia - Kent Holtorf, MD

Thyroid Disorders - Kent Holtorf, MD

Traumatic Stress…  - Ulrich Lanius, PhD

Report on LDN Study - “Skip” Lenz, PharmD

Dietary Triggers of Pain and Inflammation - Tom O’Bryan, DC, CCN, DACBN

Testing - Armin Schwarzbach, MD, PhD

Sexual Function - Mark Shukhman, MD

Autism - Brian Udell , MD

Restless Legs Syndrome - Leonard Weinstock, MD

Sarcoidosis - Leonard Weinstock, MD

Ulcerative Colitis - Leonard Weinstock, MD

Calming microglia: a future method for treating multiple sclerosis - Dr Jarred Younger, PhD

Q & A part 1 - LDN 2016 Conference
Q & A part 2 - LDN 2016 Conference
Q & A part 3 - LDN 2016 Conference
Q & A part 4 - LDN 2016 Conference
Q & A part 5 - LDN 2016 Conference